Leleu, Xavier Beksac, Meral Chou, Takaaki Dimopoulos, Meletios Yoon, Sung-Soo Prince, H Miles Pour, Ludek Shelekhova, Tatiana Chari, Ajai Khurana, Monica others, Efficacy and safety of weekly carfilzomib (70 mg/m2), dexamethasone, and daratumumab (KdD70) is comparable to twice-weekly KdD56 while being a more convenient dosing option: a cross-study comparison of the CANDOR and EQUULEUS studies, Leukemia & Lymphoma, (62), 358--367, 2021, Taylor & Francis, 1042-8194, 1029-2403